Abstract
Two Binding sites for benzodiazepines in brain which have high affinity and show saturability and stereospecificity have been described (Squires and Braestrup, 1977; Mohler and Okada, 1977a) . These binding sites appear to represent sites of pharmacological actions of benzodiazepines based upon the high degree of correlation between the ability of a series of benzodiazepines to displace binding of r3H]diazepam from the high affinity sites in brain and their activity in a number of behavioral tests including conflict, muscle relaxant, and anticonvulsant tests (Talhnan et al., 1980a) . In such tests, one of the most potent compounds observed is clonazepam, 5-(0-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one; in addition, clonazepam is a potent (Ki < 2 DM) displacer of r3H]diazepam binding to brain specific sites (Braestrup et al., 1977; Mohler and Okada, 1977b) . At the other end of the spectrum of potency is R05-4864, 7-chloro-1,3-dihydro-1-methyl-5-( p-chlorophenyl)-2H-1,4-benzodiazepin-2-one, which elicits none of the behavioral effects of the benzodiazepines and is relatively inactive (Ki > 100 PM; Braestrup et al., 1977) in displacing [3H]-diazepam from the high affinity sites in brain. The lack of potency of R05-4864 is particularly striking because it is quite similar to diazepam, differing only by possessing a p-chloro substituent.
In addition to brain, initial investigations of the binding of [3H] diazepam indicated that specific high affinity binding of [3H]diazepam could be obtained in several peripheral tissues including kidney (Braestrup et al., 1977 Braestrup et al., 1977) . Thus, although peripheral tissues possess high affinity sites for diazepam, those sites seem to be different from the central sites (Table I) .
In addition to the kidney, the "peripheral sites" seem to be on cultured cells of various types, including those of presumptive neuronal origin (Syapin and Skolnick, 1979; Strittmatter et al., 1979; Guidotti et al., 1979; Tallman et al., 1980b) . Both rat astrocytoma (Syapin and Skolnick, 1979; Tallman et al., 1980b) and neuroblastoma (Syapin and Skolnick, 1979; Guidotti et al., 1979; Tallman et al., 1980b) 
Materials
and Methods Cerebral cortices from fetal rats (Sprague-Dawley/Taconic Farms) in the 14th or 15th day of gestation were removed and single cell suspensions were prepared by trituration of the pooled tissue from three to five pregnant rats (15 to 20 passes in a Pasteur pipette) in calciumfree Eagle's minimal essential medium (see below). The cell suspensions were filtered through HD 155 Nitex mesh (Nitex Co.) and cells were counted in a Coulter model ZBI counter.
Cells were cultured in Eagle's minimal essential medium supplemented with nonessential amino acids and 10% fetal calf serum; gentamicin sulfate was routinely added to a final concentration of 50 pg/ml. This medium is referred to as MEM. Incubation was at 37°C in a humidified atmosphere of 5% COZ, 95% air.
"Neuronal" and "'non-neuronal" cultures. Cells were seeded in MEM on collagen-coated plastic Petri dishes at a cell density of 50,000 to 90,000 cells/cm'. After 72 hr incubation, the medium was replaced with fresh MEM. In the case of the "neuronal" cultures, the medium was supplemented additionally with 20 pg/ml of cytosine arabinoside, which is reportedly selectively toxic for dividing cells (Furlong and Gresham, 1971) . After an additional 24 hr incubation, the medium was aspirated, the dish was washed once with 10 ml of MEM, and fresh MEM was added. Cultures treated in this manner were harvested on the 5th and 11th day of incubation. Cultures not exposed to cytosine arabinoside, in which other cell types appeared to overgrow the neurons, were harvested on 11th day and are referred to as "non-neuronal" cultures.
"Neuronal enriched" cultures. Cells were seeded in MEM in collagen-coated plastic Petri dishes (100 mm diameter) at a cell density of 350,000 cells/cm'. After 24 hr incubation, the MEM was replaced with Medium #l as described by Sotelo et al. (1980) containing modified Dulbecco-Vogt medium with 10% fetal calf serum, 10%
horse serum, 15 mM HEPES (4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid) buffer (instead of NaHC03), 80 units/liter of insulin, 50 pg/rnl of gentamicin sulfate, and dextrose in a final concentration of 10 mg/ml. Final pH was 7.2 to 7.4. After 4 days in Medium #l, the culture medium was replaced with Medium 81 containing 4 pg/ ml of cytosine arabinoside. On day 9 in culture, Medium #l was replaced with Medium #2 as described by Sotelo et al. (1980) . Medium #2 was similar to Medium #l but no fetal calf serum was added, horse serum concentration was increased to 20%, and cytosine arabinoside was included in a concentration of 10 pg/ml. Medium #2 was replaced with fresh Medium #2 on day 15 in culture. Cells were harvested at 20 days in culture and are referred to as "neuronal enriched" cultures.
'%ibroblast" cultures. Fetal cortical cells were seeded on uncoated, 60-mm diameter, plastic Petri dishes in MEM at a cell density of 150,000 cells/cm'. The medium was changed on the 3rd, 5th, and 9th days of incubation. On the 12th day, one Petri dish, which appeared confluent with a variety of cell types, was trypsinized by standard procedures and the cells were transferred to a single 75-cm2 tissue culture flask. Thereafter, these cells, which appeared fibroblastoid in morphology, were maintained in culture by standard methods (i.e., the medium was replaced on Mondays and Wednesdays and the culture was split 15 after trypsinization each Friday). Benzodiazepine binding was measured on membranes prepared from these cells in the third passage.
Cs cultures. Rat glioma line Cg (CC1 107) was originally obtained from American Type Culture Collection, Rockville, MD. CS cells (41 to 68 passages) were grown in Dulbecco's minimal essential medium with 4.5 mg/ml of glucose, 5% fetal calf serum, and 4 mM L-glutamine as previously described (Strittmatter et al., 1979) . Cultures were propagated in Falcon plastic culture flasks at 37°C in a humidified atmosphere of 5% Con, 95% air and assayed after they had become confluent, 4 to 5 days after seeding.
Preparation of membranes from cell cultures for binding assay. For binding studies, the medium was carefully aspirated from the culture plate and the cells were rinsed with 2 ml of ice cold phosphate-buffered saline (PBS; pH 7.4). Cells were removed from the culture plates with a rubber spatula and added to a centrifuge tube in 4 ml of PBS. The cells were pelleted by low speed centrifugation (3000 x g, 10 min) at 4°C and the supernatant was aspirated. Membrane fragments were prepared by a 30-set sonication (Kontes Ultrasonic Cell Disrupter; 5.2 total watts) in 1.5 ml of cold Tris-HCl buffer.
["H]Diazepam binding was measured in washed membrane fragments by diluting and sonicating membrane fragments in 5 ml of Tris-HCl buffer (0.05 M; pH 7.4 at 4°C). The suspension was centrifuged at 18,000 x g for 10 min. This washing procedure was repeated two additional times. The final tissue pellet was resuspended in 1.0 to 1.5 ml of Tris-HCl and a 100~~1 aliquot (containing 0.1 to 0.3 mg of protein) was assayed for [3H]diazepam binding as described under "Benzodiazepine binding assay." Kainic acid lesions. A total of 17 male Sprague-Dawley rats (Taconic Farms/220 to 260 gm) were used in these experiments.
One or 2 pg of kainic acid (Sigma, St. Louis, MO) was dissolved in 1 ~1 of phosphate-buffered saline (PBS, pH 7.4) and injected over a 3-min period into the right striatum. Coordinates adapted from Kiinig and Klippel (1970) (AP 7.9, L 2.6, V 4.5) were employed. Control (sham) injections of 1 ~1 of PBS were made in the contralateral striatum of each animal. Fourteen days post-injection, rats were decapitated and their striata were rapidly dissected at 4°C. Each lesioned and control striatum was analyzed individually for both benzodiazepine binding and glutamic acid decarboxylase (GAD) activity. Striata weighing 47 + 1 mg were homogenized in 50 vol (w/v) of 0.05 M Tris-HCl buffer, pH 7.5 at 4°C. Following homogenization, a 100~~1 aliquot was removed for analysis of GAD activity as described below. The remaining fraction was used for benzodiazepine binding measurements.
Tissue homogenization and preparation for binding assay. Brain tissue samples were prepared by sonication for 30 set at 5.2 total watts using a Kontes Ultrasonic Cell Disrupter in ice cold 0.05 M Tris-HCl buffer (pH 7.4 at 4°C). Tissues were diluted to 5 mg of tissue/100 ~1. After 100 ~1 of homogenate was removed for GAD activity analysis, the sample was resuspended in 50 vol of Tris buffer, rehomogenized, and spun at 18,000 X g for 10 min. The membrane pellet then was resuspended in 50 vol (w/ v) of Tris (0.05 M, pH 7.5) and centrifuged at 18,000 X g four additional times to remove endogenous GABA (yaminobutyric acid) (Gallager et al., 1980b) . Washed membranes were suspended in cold 0.05 M Tris to a final concentration of 0.2 to 0.5 mg of protein/100 ~1. Benzodiazepine binding was assayed as described under "Benzodiazepine binding assay." Proteins were determined for each sample according to Lowry et al. (1951) and data is expressed per milligram of protein.
Analysis of GAD actiuity. To 100 ~1 of fresh or frozen (-70°C)) thawed homogenate, 50 ~1 of a solution containing 50 mM potassium phosphate buffer (KPB; pH 6.9), 0.2 mu pyridoxal phosphate (PP), 1 mM S-(2-aminoethylhsothiuronium bromide hydrobromide (AET), 0.1 mM EDTA (ethylenediaminetetraacetate), and 0.25% (w/ v) Triton X-100 was added. Samples were rehomogenized in a glass-glass homogenizer on ice and centrifuged for 30 min at 18,000 x g. Forty microliters of the resulting supernatant was added to 10 ~1 of a mixture containing 20 mM L-monopotassium glutamate, 200 mu KPB (pH 6.9)) 1 mM AET, and 0.2 mM PP with 0.5 &i of L-[l-14C]glutamic acid. The assay was run in duplicate and carried out according to the method of Tappez et al. (1976) with an incubation time of 60 min at a temperature of 37°C. Proteins were determined by the method of Lowry et al. (1951) and the assay was linear at various protein concentrations up to 60 min.
Benzodiazepine binding assay. Benzodiazepine binding to membranes from brain or cell culture tissues was measured using an incubation volume of 500 1.11 consisting of: 100 ~1 of homogenate, 350 ~1 of Tris-HCl buffer or drug dissolved in Tris buffer, and 50 1.11 of [3H]diazepam (specific activity, 83.5 Ci/mmol, New England Nuclear, Boston) in a concentration of 5 nM. When [3H]flunitrazepam was used as the benzodiazepine radioligand, (specific activity, 88 Ci/mmol, New England Nuclear, Boston), it too was added in a concentration of 5 nM. Incubations were carried out at 4'C for 30 min and terminated by rapid filtration through Whatman GF/B filters with two 7-ml washes of ice cold Tris-HCl buffer. Filters were suspended in 10 ml of Aquassure (New England Nuclear, Boston) and radioactivity was measured with a Beckman liquid scintillation spectrometer. 
Results
In vitro studies Primary cell culture. In longitudinal studies starting from the same dissection, primary cortical "neuronal" cultures grown in Eagle's minimal essential medium had measurable total diazepam binding which increased with age in culture from 214 fmol/mg of protein on day 5 to 447 fmol/mg of protein on day 11 (Fig. 1, neuronal) . In these cultures which had been treated with the antimitotic agent, cytosine arabinoside (Furlong and Gresham, 1971) ) a diminution of non-neuronal cells occurred, evidenced in light microscopic examination (R. Henneberry, unpublished observations).
[3H]Diazepam binding to membranes in these neuronal cultures was maximally displaced by 10e7 M clonazepam (Ki = 5 X lo-') while R05-4864 had little potency at this concentration (Ki > lop5 M) (Fig. 2, neuronal) . This is similar to pharmacology observed in adult rat cortex (Table I ). The ratio of clonazepam ( lop7 M)-displaceable [3H]diazepam binding to R05-4864 ( 10e7 M)-displaceable [3H]diazepam binding was 2.2 at both 5 and 11 days in culture. In contrast, cultures started from the same dissection as the "neuronal" cultures but not treated with an antimitotic agent showed an apparent overgrowth of non-neuronal elements and were designated "non-neuronal" cultures. However, no attempt was made to remove possible remaining neurons from these "non-neuronal" cultures. These "non-neuronaI" cultures had less total [3H]diazepam binding (294 fmol/mg of protein) at 11 days in culture than the "neuronal" cultures (Fig. 1, non-neuronal) . In addition, R05-4864 was more potent in displacing [3H]diazepam than was clonazepam (Fig. 2 , nonneuronal). In these "non-neuronal" cultures, the ratio of clonazepam (10e7 @-displaceable to R05-4864 (10e7 M)-displaceable binding was 0.88.
In 20-day cortical cultures from a separate dissection, media conditions were altered to enhance selectively neuronal growth and differentiation according to the method of Sotelo et al. (1980) . In this "neuronal enriched,' culture, total benzodiazepine binding (529 fmol/ mg of protein) was approximately the same as previously observed for "neuronal" cultures grown in the less selective media (Eagle's minimal essential medium, Fig. 1 (Fig. 1, fibroblasts, CS glioma) . However, this benzodiazepine binding was displaced maximally by lop7 M R05-4864 (apparent Ki = 5 X lo-' M) and only slightly displaced by lop7 M clonazepam (apparent Ki = 2 X 1O-6 M) (Fig. 2, fibroblasts) . Ratio of 10e7 M clonazepam-displaceable to 10m7 M R05-4864-displaceable [3H]diazepam binding in these continuous cell cultures was 0.13 ( fibroblasts, Fig. 1 ) and 0.03 (CS glioma, Fig. 1 ).
These data from both primary cell cultures and continuous cell cultures suggest that clonazepam displaces primarily neuronal [3H]diazepam binding while R05-4864 displaces primarily non-neuronal binding. However, it is not certain whether binding sites in cultured tissues are identical to those observed in the intact mammalian CNS. Thus, a second series of experiments explored the pharmacological characterization of binding sites within the CNS with intact and lesioned neurons.
In vivo studies
Kainic acid lesions. Intrastriatal injection of kainic acid (KA) has been reported to produce striatal neuronal degeneration (Olney et al., 1974; Schwartz and Coyle, 1977) and gliosis (Wuerthele et al., 1978; Nicklas et al., 1979 Chang et al., 1980) lesion-induced decrease in GAD activity (ratio of GAD activity in lesioned striatum versus GAD activity in sham-lesioned striatum) and the ratio of clonazepamdisplaceable ( 10m7 M)/R05-4864-displaceable ( 10m7 M) [3H]diazepam binding in lesioned striatum (RL) to the ratio of clonazepam-displaceable ( 1O-7 M)/R05-4864-displaceable (10e7 M) [3H]diazepam binding in sham-lesioned striatum (Rs) (Fig. 3) .
These in uiuo data further reinforce the view that neuronal and non-neuronal [3H]diazepam binding sites within the central nervous system are pharmacologically distinguishable. As previously observed (Speth et al., 1978; Braestrup et al., 1979) and apparent from the data in Table II, [3H]flunitrazepam appears to bind with greater sensitivity than r3H]diazepam to CNS tissue. However, a direct comparison of these benzodiazepine radioligands in the same tissue homogenates indicates that [3H]flunitrazepam does not bind to any significant degree (at the concentration used) to the R05-4864-displaceable site (Table II) 
Discussion
The results presented in this paper demonstrate that mammalian central nervous tissue contains at least two pharmacologically distinct benzodiazepine binding sites. Both in vitro cell cultures and in viuo lesion preparations have been utilized to determine the cellular localization of these two binding sites.
Cell culture techniques have been shown to be important for investigating various aspects of neuron and glial cell growth and differentiation. Primary neuronal cultures from rodent cortical cultures exhibit some of the biochemical (Raff et al., 1979; Hansson et al., 1980; Snodgrass et al., 1980; Sotelo et al., 1980) and physiological (Barker and Ransom, 1978; Dichter, 1978; MacDonald and'Barker, 1978) properties characteristic of the central nervous system.
Benzodiazepine binding in primary cortical cultures has also been described by several laboratories (Dudai et al., 1979; Harden and McCarthy, 1979; Hertz and Mukerji, 1980; Huang et al., 1980) . In these previous studies, benzodiazepine binding is most potently displaced by centrally active benzodiazepines, analogous to the pharmacological profile observed in cerebral tissue from adult (Braestrup et al., 1977; Mohler and Okada, 1977a, b; Tallman et al., 1980b) and postnatal animals (Braestrup and Nielson, 1978; Candy and Martin, 1979; Mallorga et al., 1980) . However, the present studies have also demonstrated a significant amount of displacement of membrane-bound [3H]diazepam by the centrally "inactive" benzodiazepine, R05-4864. Displacement of membranebound [3H]diazepam by R05-4864 has been observed previously to be significant in transformed neuronal and glial cell cultures (Braestrup et al., 1978; Chang et al., 1978; Guidotti et al., 1979; Hertz and Mukerji, 1980; Strittmatter et al., 1979; Syapin and Skolnick, 1979). Vol. 1, No. 2, Feb. 1981 Since our primary cortical cultures contained mixed populations of neurons, glia, and other non-neuronal elements, we wished to determine whether the pharma- (Braestrup et al., 1978) . In the present experiments, displacement curves for ["Hldiazepam were obtained using a relatively high concentration (5 nM) of the radioligand in order for both sites to be measured. One study reported observing no differences in benzodiazepine binding affinities between selectively cultured populations of neurons and glia (Dudai et al., 1979) Chang et al., 1980) . However, these lesions did dramatically increase the amount of R05-4864-displaceable ["Hldiazepam binding and significantly altered the ratio of clonazepam-to R05-4864-displaceable binding. Such an effect could explain the decrease in binding affinity for ["HIdiazepam following kainic acid lesions observed by Biggio et al. (1979) .
To determine the extent of neuronal damage, GAD, the biosynthetic enzyme for GABA, activity was determined. A significant correlation between the ratio of these two types of displaceable binding and GAD activity within the same tissue homogenate has also been shown. These experiments demonstrate that the extent of neuronal destruction is related to the ratio of clonazepam-to R05-4864-displaceable [3H]diazepam binding. Although an intimate interaction between GABA and benzodiazepine binding has been reported previously (Tallman et al., 1980a) , GAD activity is used in these studies as a measure of neuronal damage (McGeer and McGeer, 1978) . It cannot be determined from our studies whether benzodiazepine binding sites are located principally on GABAergic neurons. However, several reports now suggest such a correlation (Huang et al., 1980; Mohler et al., 1980 (Gallager et al., 1980a ) manipulations which alter cell survival and/or proliferation within the mammalian nervous system.
